Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
That should read exciting not exiting, I'm going nowhere on relisting lol.
and this is the clue, Revolutions chocolate pallette:
https://www.revolutionbeauty.com/uk/en/makeup/face/highlighter/i-heart-revolution-rose-gold-glow-mini-chocolate-highlighter-palette/30023-01.html
Revolution's collaboration with Primark, things are getting very exiting indeed.
https://www.thesun.co.uk/fabulous/22067954/primark-teases-new-make-up-brand-collaboration/
Spectral MD Holdings Ltd is to delist from AIM and shift to Nasdaq through a merger with a SPAC vehicle that values the wound assessment specialist at a huge premium to its current UK-listed value.
At present, Spectral’s market cap is around £38mln but the deal with Rosecliff Advisors values it at US$170mln (£136mln) or 101p a share, a 260% uplift to its current share price.
Spectral MD added the shift will also give access to new shareholders, sources of capital and the US government, currently its major customer.
Up to this point, the company has received US$125mln in grant funding from US agencies and said it wants to be ideally positioned for future federal contracts, particularly for burn assessments using its DeepView AI technology.
Trials of the AI-based product are ongoing across the US and Spectral MD added it expects to receive a "significant" contract for DeepView’s commercialisation.
As part of the Rosecliff transaction, Spectral will receive gross proceeds of US$20mln comprised of a placing and US$4.5mln held by the SPAC.
Completion is expected by the third quarter of this year and will be accompanied by a name change to Spectral AI.
Wensheng Fan, Spectral’s managing director, said: "This transaction is an excellent strategic move for Spectral MD.
“The Nasdaq listing will ensure we are well positioned to capitalize on US federal procurement contracts, our planned FDA and CE mark submissions in 2023 and 2024, and our commercialisation roadmap for burn, DFU, 3-D wound size measurement.
https://www.proactiveinvestors.co.uk/companies/news/1011677/spectral-md-shifts-to-nasdaq-from-aim-at-huge-premium-1011677.html
Took me less than a minute on AJ Bell, a few tick boxes and done. Just wait for NASDAQ listing then confirmation of contracts to come in, they will already know what is coming up in that respect IMO, I don't think they would go through the trouble of a merger and delisting form AIM and relisting on the NASDAQ on a whim.
So basically they are delisting from the AIM and relisting on the NADAQ at the equivalent of 101p per share, is it just me or am I missing the easiest bag on the market at the moment?
AVEVA, a global leader in industrial software driving innovation and sustainability, has signed a memorandum of understanding (MoU) with Petrofac, a leading provider of services to the global energy industry.
The new agreement will see AVEVA cooperate with Petrofac towards:
Digital transformation of the end-to-end supply chain system process, including engineering cataloging, procurement, site material control and construction planning
Supporting the delivery of Petrofac’s net-zero targets using AVEVA’s sustainable engineering solutions
The plan includes, cooperation kick-off, design thinking sessions for new solutions and use cases, technical assessments, an execution strategy and more.
George Eapen, Group CIO, Petrofac said: “Petrofac and AVEVA have a long-standing relationship and we are very happy to partner with them to build on to our multi-year digital transformation strategy. As part of our agreement, we will build digital capabilities internally and for our customers that are aligned to Petrofac’s environmental, social and governance (ESG) and sustainability agendas.”
- Advertisement -
Caspar Herzberg, CEO, AVEVA said: “AVEVA’s solutions drive measurable emission reductions across scopes 1, 2 and 3, helping industrial companies to meet climate commitments aligned to the Paris Agreement. We are delighted to be able to support Petrofac in accelerating the energy transition for their customers, by deriving data-led insights that unlock more efficient ways of working and drive responsible use of our world’s resources.”
Under the MoU, Petrofac will also explore the deployment of AVEVA Enterprise Resource Management (ERM) and AVEVA Process Simulation in its engineering delivery services, while replacing legacy inhouse and third-party solutions. The new AVEVA solutions will provide Petrofac with value chain visibility and secure audit trails for tracking material procurement, minimizing waste and ensuring regulatory compliance.
AVEVA’s pioneering software integrates with existing systems to transform siloed supply chains, enabling companies to execute sustainable projects by optimizing resources, reducing material and shipping waste, and delivering efficiency and optimization gains.
Not sure what it means in monetary terms but progress is progress.
https://www.itnewsafrica.com/2023/04/aveva-and-petrofac-enter-mou-to-accelerate-digital-initiatives-for-the-energy-industry/
Below are the bottom 5 in the FTSE 250, we already have a higher market cap than NCC but the promotions to the FTSE250/100 are every quarter so we have just missed March, the next round of promotions/demotions will be June so we could qualify by that time if the market cap holds up and continues increases by then.
NCC NCC GROUP PLC ORD 1P GBX 287.06 91.10 -0.90 -0.98%
VID VIDENDUM PLC ORD 20P GBX 403.46 858.00 -8.00 -0.92%
HTG HUNTING PLC ORD 25P GBX 408.23 244.50 -3.00 -1.21%
GROW MOLTEN VENTURES PLC ORD GBP0.01 GBX 423.50 266.40 -10.40 -3.76%
WHR WAREHOUSE REIT PLC ORD 1P GBX 446.95 104.80 -0.40 -0.38%
50-1 rights issue, I don't think you under stand the magnitude of the ridiculous nonsense you write, the market cap is currently just over £400m with 500m shares in issue, now times both of them amounts individually by 50 which is what you suggest and that is the amount you are suggesting they will raise, for info that's £20b raised and 25b shares in issue, PMSL.
The times has covered it, although it is behind a pay wall so not been able to read it.
https://www.thetimes.co.uk/article/contracts-power-a-revival-at-petrofac-3lggbcbjt
Try not to worry yourself too much esecallum, with $511m liquidity, I don't think there will be any need for a raise.
"The firm had $511m in liquidity, so there wasn’t an immediate danger."
https://uk.news.yahoo.com/petrofac-share-price-just-jumped-140347427.html
Posted by AZ on linked in:
"I'm not sure it's correct to consider financial instruments/ products tokenised as "real world assets". Anycase, Supply@ME Capital plc tokenised inventories for € 1,6m with vechain and in last business update the company said that is compiling a further portfolio up to USD 50m. #staytuned #SYME #inventorymonetisation"
https://www.linkedin.com/feed/update/urn:li:activity:7047618181913280514/
On the back of that we should now start tom see a reversal in the direction of the share price, this is now a very good opportunity to take a position for a long term hold in a company on the up again, remember Petrofac were once the leaders in their field and will be again in my opinion.
Genedrive PLC - Manchester, England-based point-of-care molecular diagnostics company - Reports revenue in the six months to December 31 of GBP20,000 compared to nothing a year prior, and an operating loss of GBP2.7 million from GBP2.8 million. Confident that the company will see an acceleration of revenues through 2023 and going forwards. Agrees GBP5 million equity prepayment facility with Riverfort Global Opportunities PCC Ltd with an initial drawn amount of GBP2 million, expected to be received in early April. Proceeds will be used towards the commercialisation of the antibiotic induced hearing loss test, Genedrive MT-RNR1 ID Kit and enhancing the Genedrive platform as well as providing additional working capital. Directors believe the facility is the best option available at present.
Current stock price: 28.50 pence